BeStock  
Stocks › Biotechnology › ACRS

Aclaris Therapeutics ACRS

US equityMarket cap rank #3745Biotechnology
$3.40 −$0.30 (-8.11%)
Pre-market · Oct 8, 9:10 am ET · After hours $3.46 +1.76%
Open$3.60
Prev close$3.70
Day range$3.32 – $3.62
Volume9.00M
Market cap$500.48M
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±6.6%last 16 reports
Closed higher4 of 1625% of the time
Best reaction+20.4%
Worst reaction-10.2%

Stock move on the day after each report

-8.5%2017/Q3-7.2%2017/Q4-2.0%2018/Q1-1.5%2018/Q2+2.3%2018/Q3+20.4%2018/Q4-9.8%2019/Q1-9.1%2019/Q2+15.4%2019/Q3-10.2%2019/Q4-6.5%2023/Q1-9.0%2024/Q1
QuarterReport dateTimingImplied moveActual moveVersus implied
2024/Q17 May 2024After Market±35.1%-8.96%Within range
2023/Q18 May 2023Pre Market±12.5%-6.46%Within range
2019/Q425 Feb 2020None–-10.22%–
2019/Q37 Nov 2019After Market–+15.38%–
2019/Q28 Aug 2019After Market–-9.08%–
2019/Q18 May 2019After Market–-9.82%–
2018/Q418 Mar 2019Pre Market–+20.43%–
2018/Q36 Nov 2018After Market–+2.30%–
2018/Q23 Aug 2018Pre Market–-1.52%–
2018/Q18 May 2018After Market–-1.96%–
2017/Q412 Mar 2018None–-7.19%–
2017/Q37 Nov 2017Pre Market–-8.45%–
2017/Q28 Aug 2017Pre Market–-1.00%–
2017/Q19 May 2017Pre Market–-0.52%–
2016/Q415 Mar 2017Pre Market–+0.56%–
2016/Q33 Nov 2016Pre Market–-1.71%–

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Discussion

No comments yet — be the first to weigh in on ACRS.

Leave a comment

Scroll to Top